Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.52727756 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.52727756 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.23250340 |
4 | positive regulation of interferon-alpha production (GO:0032727) | 4.82323707 |
5 | * response to type I interferon (GO:0034340) | 4.59540967 |
6 | * type I interferon signaling pathway (GO:0060337) | 4.58126516 |
7 | * cellular response to type I interferon (GO:0071357) | 4.58126516 |
8 | regulation of interferon-alpha production (GO:0032647) | 4.55267828 |
9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.50796503 |
10 | negative regulation of cell killing (GO:0031342) | 4.50796503 |
11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.42967119 |
12 | modulation by symbiont of host defense response (GO:0052031) | 4.22512011 |
13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.22512011 |
14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.22512011 |
15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.22512011 |
16 | modulation by symbiont of host immune response (GO:0052553) | 4.22512011 |
17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.22512011 |
18 | response to interferon-alpha (GO:0035455) | 4.12945993 |
19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.89501158 |
20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.86138700 |
21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.85613005 |
22 | negative regulation of interleukin-12 production (GO:0032695) | 3.72153664 |
23 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.61709160 |
24 | detection of other organism (GO:0098543) | 3.57958813 |
25 | immunoglobulin mediated immune response (GO:0016064) | 3.51886039 |
26 | neutrophil activation involved in immune response (GO:0002283) | 3.49176540 |
27 | macrophage activation involved in immune response (GO:0002281) | 3.48147915 |
28 | detection of bacterium (GO:0016045) | 3.44900692 |
29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43368900 |
30 | regulation of RIG-I signaling pathway (GO:0039535) | 3.42998669 |
31 | detection of external biotic stimulus (GO:0098581) | 3.34984586 |
32 | positive regulation of interferon-beta production (GO:0032728) | 3.34389627 |
33 | response to host immune response (GO:0052572) | 3.26016615 |
34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26016615 |
35 | cellular response to virus (GO:0098586) | 3.24702036 |
36 | negative regulation of viral genome replication (GO:0045071) | 3.22878895 |
37 | cellular response to interferon-beta (GO:0035458) | 3.21951189 |
38 | NIK/NF-kappaB signaling (GO:0038061) | 3.20087962 |
39 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.17048989 |
40 | positive regulation of type 2 immune response (GO:0002830) | 3.16740029 |
41 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.16533979 |
42 | regulation of T cell tolerance induction (GO:0002664) | 3.16527692 |
43 | response to peptidoglycan (GO:0032494) | 3.15389203 |
44 | complement activation, alternative pathway (GO:0006957) | 3.13867555 |
45 | cellular response to interferon-alpha (GO:0035457) | 3.13501221 |
46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.09679223 |
47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.09033995 |
48 | positive regulation of humoral immune response (GO:0002922) | 3.06286561 |
49 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05391892 |
50 | T-helper 1 type immune response (GO:0042088) | 3.04623542 |
51 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.03527419 |
52 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03426003 |
53 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.02571522 |
54 | protein carboxylation (GO:0018214) | 3.02571522 |
55 | cellular response to exogenous dsRNA (GO:0071360) | 3.01603783 |
56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00457771 |
57 | response to interferon-beta (GO:0035456) | 3.00100181 |
58 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.97394364 |
59 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.96519213 |
60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95690090 |
61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95050394 |
62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92789630 |
63 | response to host (GO:0075136) | 2.92789630 |
64 | response to host defenses (GO:0052200) | 2.92789630 |
65 | regulation of cholesterol storage (GO:0010885) | 2.90809020 |
66 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90534238 |
67 | plasma lipoprotein particle clearance (GO:0034381) | 2.90412827 |
68 | regulation of type 2 immune response (GO:0002828) | 2.89300571 |
69 | cellular response to interferon-gamma (GO:0071346) | 2.88864661 |
70 | detection of biotic stimulus (GO:0009595) | 2.88845999 |
71 | regulation of tolerance induction (GO:0002643) | 2.88480518 |
72 | cellular extravasation (GO:0045123) | 2.85986426 |
73 | germinal center formation (GO:0002467) | 2.85561679 |
74 | phospholipid efflux (GO:0033700) | 2.85218858 |
75 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.83391731 |
76 | regulation of protein activation cascade (GO:2000257) | 2.82732464 |
77 | regulation of gamma-delta T cell activation (GO:0046643) | 2.81776344 |
78 | defense response to protozoan (GO:0042832) | 2.80247107 |
79 | tryptophan catabolic process (GO:0006569) | 2.79509041 |
80 | indole-containing compound catabolic process (GO:0042436) | 2.79509041 |
81 | indolalkylamine catabolic process (GO:0046218) | 2.79509041 |
82 | microglial cell activation (GO:0001774) | 2.79404823 |
83 | * defense response to virus (GO:0051607) | 2.78847986 |
84 | negative regulation of innate immune response (GO:0045824) | 2.77572600 |
85 | urea cycle (GO:0000050) | 2.77546934 |
86 | urea metabolic process (GO:0019627) | 2.77546934 |
87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.75696638 |
88 | natural killer cell mediated immunity (GO:0002228) | 2.74962825 |
89 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.74962825 |
90 | regulation of activation of Janus kinase activity (GO:0010533) | 2.73946986 |
91 | granulocyte activation (GO:0036230) | 2.73945959 |
92 | positive regulation of interleukin-12 production (GO:0032735) | 2.73784887 |
93 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73726823 |
94 | aromatic amino acid family catabolic process (GO:0009074) | 2.71918813 |
95 | kynurenine metabolic process (GO:0070189) | 2.71834102 |
96 | positive regulation of B cell differentiation (GO:0045579) | 2.71744462 |
97 | response to protozoan (GO:0001562) | 2.71274348 |
98 | low-density lipoprotein particle clearance (GO:0034383) | 2.70231536 |
99 | regulation of complement activation (GO:0030449) | 2.69961319 |
100 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.68720205 |
101 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.66154858 |
102 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.65792033 |
103 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.65380166 |
104 | tryptophan metabolic process (GO:0006568) | 2.65208660 |
105 | macrophage activation (GO:0042116) | 2.65188478 |
106 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.65016605 |
107 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.65012015 |
108 | regulation of hypersensitivity (GO:0002883) | 2.64568382 |
109 | T cell migration (GO:0072678) | 2.64233300 |
110 | response to muramyl dipeptide (GO:0032495) | 2.63979876 |
111 | I-kappaB phosphorylation (GO:0007252) | 2.63897940 |
112 | L-phenylalanine catabolic process (GO:0006559) | 2.63413511 |
113 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.63413511 |
114 | lymphocyte chemotaxis (GO:0048247) | 2.63410425 |
115 | growth hormone receptor signaling pathway (GO:0060396) | 2.63037831 |
116 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.62859272 |
117 | detection of molecule of bacterial origin (GO:0032490) | 2.62446332 |
118 | neutrophil activation (GO:0042119) | 2.62271605 |
119 | negative regulation of type 2 immune response (GO:0002829) | 2.62209364 |
120 | high-density lipoprotein particle remodeling (GO:0034375) | 2.62029650 |
121 | cellular response to ethanol (GO:0071361) | 2.61831441 |
122 | interferon-gamma secretion (GO:0072643) | 2.61576674 |
123 | leukocyte aggregation (GO:0070486) | 2.61425433 |
124 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.60881423 |
125 | phospholipid homeostasis (GO:0055091) | 2.60361099 |
126 | respiratory burst (GO:0045730) | 2.60220973 |
127 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.59569840 |
128 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.59408342 |
129 | negative regulation of bone resorption (GO:0045779) | 2.59328612 |
130 | negative regulation of lipid storage (GO:0010888) | 2.58471160 |
131 | regulation of antigen processing and presentation (GO:0002577) | 2.57044660 |
132 | negative thymic T cell selection (GO:0045060) | 2.57022239 |
133 | response to interleukin-15 (GO:0070672) | 2.56892749 |
134 | response to interferon-gamma (GO:0034341) | 2.56780421 |
135 | myeloid cell activation involved in immune response (GO:0002275) | 2.56497771 |
136 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.56153947 |
137 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.51055571 |
138 | positive regulation of defense response to virus by host (GO:0002230) | 2.49695105 |
139 | positive regulation of tolerance induction (GO:0002645) | 2.47796914 |
140 | B cell mediated immunity (GO:0019724) | 2.46577796 |
141 | negative T cell selection (GO:0043383) | 2.46142221 |
142 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.45824617 |
143 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.44868643 |
144 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.44868643 |
145 | negative regulation of viral process (GO:0048525) | 2.42241951 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.69345121 |
2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.46666381 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.32510330 |
4 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.51487080 |
5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.95480647 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.66604410 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.49168456 |
8 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.36182115 |
9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.06453061 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05206004 |
11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.94870716 |
12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92242799 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.91728315 |
14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.86563057 |
15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.83962358 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.67246686 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.57559327 |
18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.50548956 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39272899 |
20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.37892913 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30758799 |
22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.29601041 |
23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13771541 |
24 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12032947 |
25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.10968360 |
26 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.07850304 |
27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98606814 |
28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97573859 |
29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88611067 |
30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.87780847 |
31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77650115 |
32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.74682156 |
33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74607609 |
34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67495745 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61739058 |
36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.60704615 |
37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51892575 |
38 | MYB_26560356_Chip-Seq_TH2_Human | 1.42273832 |
39 | MYB_26560356_Chip-Seq_TH1_Human | 1.40690458 |
40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40196306 |
41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34419390 |
42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33607295 |
43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33278942 |
44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30242676 |
45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29222121 |
46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29148119 |
47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25176928 |
48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24341493 |
49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23223606 |
50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22333067 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20399003 |
52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20376662 |
53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20110661 |
54 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.18164018 |
55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17118301 |
56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14414414 |
57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13000622 |
58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12686981 |
59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12017381 |
60 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08605448 |
61 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05291502 |
62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05145350 |
63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02309903 |
64 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.01504264 |
65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01417444 |
66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01369590 |
67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01111195 |
68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01061910 |
69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00591113 |
70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00004896 |
71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99711620 |
72 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98937695 |
73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97729803 |
74 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94597027 |
75 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93936832 |
76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.93586249 |
77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93255335 |
78 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92413480 |
79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91846325 |
80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91162073 |
81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90585033 |
82 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90383047 |
83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87976538 |
84 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87921745 |
85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87420486 |
86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86996710 |
87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86159281 |
88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85801190 |
89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84664618 |
90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84286954 |
91 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83216103 |
92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82436744 |
93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82319429 |
94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82302397 |
95 | MAF_26560356_Chip-Seq_TH2_Human | 0.81751469 |
96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81686992 |
97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81516544 |
98 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80916460 |
99 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80300367 |
100 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80261729 |
101 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80090455 |
102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79551320 |
103 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79525515 |
104 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79228992 |
105 | MYC_22102868_ChIP-Seq_BL_Human | 0.78314300 |
106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.78259311 |
107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76634681 |
108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76634681 |
109 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76542937 |
110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76390093 |
111 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75763254 |
112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75462624 |
113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73584824 |
114 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72816948 |
115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72595955 |
116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72303536 |
117 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.72210356 |
118 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72163826 |
119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71887300 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0001835_abnormal_antigen_presentation | 3.72343692 |
2 | MP0002139_abnormal_hepatobiliary_system | 3.40771805 |
3 | MP0005360_urolithiasis | 3.14795455 |
4 | * MP0009785_altered_susceptibility_to | 3.11398709 |
5 | MP0003436_decreased_susceptibility_to | 2.87812343 |
6 | MP0004510_myositis | 2.80925515 |
7 | MP0009840_abnormal_foam_cell | 2.80366160 |
8 | MP0005387_immune_system_phenotype | 2.78000884 |
9 | MP0001790_abnormal_immune_system | 2.78000884 |
10 | MP0003303_peritoneal_inflammation | 2.75577265 |
11 | MP0000685_abnormal_immune_system | 2.75484308 |
12 | MP0006082_CNS_inflammation | 2.62962215 |
13 | MP0003724_increased_susceptibility_to | 2.53824842 |
14 | * MP0005025_abnormal_response_to | 2.49415855 |
15 | MP0005000_abnormal_immune_tolerance | 2.40303741 |
16 | MP0002419_abnormal_innate_immunity | 2.37973909 |
17 | MP0001800_abnormal_humoral_immune | 2.32239214 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.31980132 |
19 | MP0006054_spinal_hemorrhage | 2.29679288 |
20 | MP0005365_abnormal_bile_salt | 2.28549820 |
21 | MP0005085_abnormal_gallbladder_physiolo | 2.22530845 |
22 | MP0005671_abnormal_response_to | 2.20683821 |
23 | MP0002138_abnormal_hepatobiliary_system | 2.14660453 |
24 | MP0003191_abnormal_cellular_cholesterol | 2.12609892 |
25 | * MP0002452_abnormal_antigen_presenting | 2.10391987 |
26 | MP0002723_abnormal_immune_serum | 2.10226692 |
27 | MP0005058_abnormal_lysosome_morphology | 2.10177839 |
28 | MP0004947_skin_inflammation | 2.04689048 |
29 | MP0009764_decreased_sensitivity_to | 1.88244955 |
30 | MP0005083_abnormal_biliary_tract | 1.86341416 |
31 | MP0005464_abnormal_platelet_physiology | 1.85543252 |
32 | MP0003252_abnormal_bile_duct | 1.85471364 |
33 | MP0008469_abnormal_protein_level | 1.76295296 |
34 | MP0002254_reproductive_system_inflammat | 1.75731449 |
35 | MP0005503_abnormal_tendon_morphology | 1.74519622 |
36 | * MP0001819_abnormal_immune_cell | 1.74130269 |
37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.73274763 |
38 | MP0001958_emphysema | 1.72338122 |
39 | * MP0002420_abnormal_adaptive_immunity | 1.70753832 |
40 | MP0010329_abnormal_lipoprotein_level | 1.67520584 |
41 | MP0001845_abnormal_inflammatory_respons | 1.63916742 |
42 | MP0005275_abnormal_skin_tensile | 1.63423662 |
43 | MP0002166_altered_tumor_susceptibility | 1.62947366 |
44 | MP0001533_abnormal_skeleton_physiology | 1.62797058 |
45 | MP0001853_heart_inflammation | 1.61694518 |
46 | MP0003279_aneurysm | 1.58474866 |
47 | MP0000604_amyloidosis | 1.57175893 |
48 | MP0004883_abnormal_blood_vessel | 1.56079752 |
49 | MP0010155_abnormal_intestine_physiology | 1.54917088 |
50 | MP0003300_gastrointestinal_ulcer | 1.51333639 |
51 | MP0003172_abnormal_lysosome_physiology | 1.46955447 |
52 | MP0002006_tumorigenesis | 1.46660003 |
53 | MP0000569_abnormal_digit_pigmentation | 1.44557366 |
54 | MP0000609_abnormal_liver_physiology | 1.44440229 |
55 | MP0002405_respiratory_system_inflammati | 1.40778552 |
56 | MP0008260_abnormal_autophagy | 1.35688457 |
57 | * MP0000716_abnormal_immune_system | 1.35651139 |
58 | * MP0002398_abnormal_bone_marrow | 1.29123186 |
59 | MP0003705_abnormal_hypodermis_morpholog | 1.29086287 |
60 | MP0009763_increased_sensitivity_to | 1.27543923 |
61 | MP0003448_altered_tumor_morphology | 1.26152331 |
62 | MP0005390_skeleton_phenotype | 1.24721324 |
63 | MP0003075_altered_response_to | 1.23042216 |
64 | MP0009278_abnormal_bone_marrow | 1.22040674 |
65 | MP0001542_abnormal_bone_strength | 1.21331153 |
66 | MP0005310_abnormal_salivary_gland | 1.21116313 |
67 | MP0003690_abnormal_glial_cell | 1.14852213 |
68 | MP0000689_abnormal_spleen_morphology | 1.12635754 |
69 | MP0001666_abnormal_nutrient_absorption | 1.12212759 |
70 | MP0000343_altered_response_to | 1.11686622 |
71 | MP0003453_abnormal_keratinocyte_physiol | 1.11671118 |
72 | MP0003045_fibrosis | 1.10756464 |
73 | * MP0002429_abnormal_blood_cell | 1.06820744 |
74 | MP0002998_abnormal_bone_remodeling | 1.06471636 |
75 | MP0005319_abnormal_enzyme/_coenzyme | 1.05595453 |
76 | MP0005397_hematopoietic_system_phenotyp | 1.05410988 |
77 | MP0001545_abnormal_hematopoietic_system | 1.05410988 |
78 | MP0002722_abnormal_immune_system | 1.01859212 |
79 | MP0005166_decreased_susceptibility_to | 1.00014461 |
80 | MP0001851_eye_inflammation | 0.99776565 |
81 | MP0002118_abnormal_lipid_homeostasis | 0.98970755 |
82 | MP0000015_abnormal_ear_pigmentation | 0.98469336 |
83 | MP0003866_abnormal_defecation | 0.96791729 |
84 | MP0005332_abnormal_amino_acid | 0.96124048 |
85 | MP0009333_abnormal_splenocyte_physiolog | 0.95101387 |
86 | MP0003656_abnormal_erythrocyte_physiolo | 0.94924814 |
87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94862049 |
88 | MP0000371_diluted_coat_color | 0.92620721 |
89 | MP0003806_abnormal_nucleotide_metabolis | 0.91261583 |
90 | MP0003183_abnormal_peptide_metabolism | 0.91132861 |
91 | MP0000465_gastrointestinal_hemorrhage | 0.90869784 |
92 | MP0003763_abnormal_thymus_physiology | 0.90340212 |
93 | MP0003195_calcinosis | 0.90179308 |
94 | MP0001873_stomach_inflammation | 0.90153579 |
95 | MP0000920_abnormal_myelination | 0.90138191 |
96 | MP0008438_abnormal_cutaneous_collagen | 0.89836299 |
97 | MP0000598_abnormal_liver_morphology | 0.89406977 |
98 | MP0003795_abnormal_bone_structure | 0.88477237 |
99 | MP0003828_pulmonary_edema | 0.88032837 |
100 | MP0010307_abnormal_tumor_latency | 0.87696936 |
101 | MP0000858_altered_metastatic_potential | 0.87226661 |
102 | MP0003566_abnormal_cell_adhesion | 0.85898359 |
103 | MP0002168_other_aberrant_phenotype | 0.84770911 |
104 | MP0005023_abnormal_wound_healing | 0.84326407 |
105 | MP0003950_abnormal_plasma_membrane | 0.81662624 |
106 | MP0003091_abnormal_cell_migration | 0.81611046 |
107 | MP0000249_abnormal_blood_vessel | 0.78636018 |
108 | MP0003186_abnormal_redox_activity | 0.78322644 |
109 | MP0004381_abnormal_hair_follicle | 0.75772193 |
110 | MP0009643_abnormal_urine_homeostasis | 0.74770646 |
111 | MP0005164_abnormal_response_to | 0.74264696 |
112 | MP0002136_abnormal_kidney_physiology | 0.74256985 |
113 | MP0004782_abnormal_surfactant_physiolog | 0.73836547 |
114 | MP0001348_abnormal_lacrimal_gland | 0.73274422 |
115 | MP0002332_abnormal_exercise_endurance | 0.71431757 |
116 | MP0009765_abnormal_xenobiotic_induced | 0.71239221 |
117 | MP0004808_abnormal_hematopoietic_stem | 0.71223976 |
118 | MP0004019_abnormal_vitamin_homeostasis | 0.67997033 |
119 | MP0005451_abnormal_body_composition | 0.67763609 |
120 | MP0000767_abnormal_smooth_muscle | 0.66985691 |
121 | MP0005076_abnormal_cell_differentiation | 0.66350266 |
122 | MP0002933_joint_inflammation | 0.65972847 |
123 | MP0001881_abnormal_mammary_gland | 0.65916833 |
124 | MP0001663_abnormal_digestive_system | 0.65325609 |
125 | MP0008004_abnormal_stomach_pH | 0.64982742 |
126 | MP0000703_abnormal_thymus_morphology | 0.62901135 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.91120372 |
2 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.65231117 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.45779265 |
4 | Recurrent abscess formation (HP:0002722) | 4.26642842 |
5 | Systemic lupus erythematosus (HP:0002725) | 4.26363490 |
6 | Autoimmune thrombocytopenia (HP:0001973) | 4.25328163 |
7 | Chronic otitis media (HP:0000389) | 3.96514707 |
8 | Myocardial infarction (HP:0001658) | 3.68327028 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.67378812 |
10 | Deep venous thrombosis (HP:0002625) | 3.64431850 |
11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.58796002 |
12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.58796002 |
13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.58796002 |
14 | Gingival bleeding (HP:0000225) | 3.55273140 |
15 | Complement deficiency (HP:0004431) | 3.55219405 |
16 | Abnormality of macrophages (HP:0004311) | 3.49957345 |
17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.49904095 |
18 | Recurrent viral infections (HP:0004429) | 3.38448634 |
19 | Joint hemorrhage (HP:0005261) | 3.35576928 |
20 | Recurrent fungal infections (HP:0002841) | 3.35070384 |
21 | Myositis (HP:0100614) | 3.34572450 |
22 | Recurrent skin infections (HP:0001581) | 3.33596060 |
23 | Xanthomatosis (HP:0000991) | 3.27795254 |
24 | Mediastinal lymphadenopathy (HP:0100721) | 3.25542746 |
25 | Vasculitis (HP:0002633) | 3.23469077 |
26 | Orchitis (HP:0100796) | 3.19875158 |
27 | Intrahepatic cholestasis (HP:0001406) | 3.10664080 |
28 | Prolonged partial thromboplastin time (HP:0003645) | 3.08683834 |
29 | Spondylolisthesis (HP:0003302) | 3.08213297 |
30 | Gastrointestinal infarctions (HP:0005244) | 2.96842936 |
31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.94256194 |
32 | Nasal polyposis (HP:0100582) | 2.92660402 |
33 | Glomerulonephritis (HP:0000099) | 2.91976485 |
34 | Dysostosis multiplex (HP:0000943) | 2.86616305 |
35 | Gingivitis (HP:0000230) | 2.85902455 |
36 | Abnormality of complement system (HP:0005339) | 2.85443300 |
37 | Optic neuritis (HP:0100653) | 2.81862516 |
38 | Retrobulbar optic neuritis (HP:0100654) | 2.81862516 |
39 | Keratoconjunctivitis (HP:0001096) | 2.79112847 |
40 | Abnormality of the nasal mucosa (HP:0000433) | 2.77967682 |
41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.77402870 |
42 | Abnormality of the common coagulation pathway (HP:0010990) | 2.76966768 |
43 | Periodontitis (HP:0000704) | 2.72638455 |
44 | Epidermoid cyst (HP:0200040) | 2.71508843 |
45 | Interstitial pulmonary disease (HP:0006530) | 2.66021959 |
46 | Vacuolated lymphocytes (HP:0001922) | 2.65813718 |
47 | Hyperlipoproteinemia (HP:0010980) | 2.65423049 |
48 | Mitral stenosis (HP:0001718) | 2.62824735 |
49 | Nephritis (HP:0000123) | 2.60410011 |
50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.58343129 |
51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.58343129 |
52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.58343129 |
53 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.57882317 |
54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.57882317 |
55 | Recurrent bronchitis (HP:0002837) | 2.56607338 |
56 | T lymphocytopenia (HP:0005403) | 2.54642315 |
57 | Arterial thrombosis (HP:0004420) | 2.53695545 |
58 | Increased cerebral lipofuscin (HP:0011813) | 2.53311099 |
59 | Thick nail (HP:0001805) | 2.53119830 |
60 | Joint swelling (HP:0001386) | 2.51548649 |
61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51457791 |
62 | Mucopolysacchariduria (HP:0008155) | 2.51457791 |
63 | Loss of speech (HP:0002371) | 2.50804732 |
64 | Pustule (HP:0200039) | 2.50644812 |
65 | Cellulitis (HP:0100658) | 2.50323423 |
66 | Basal ganglia calcification (HP:0002135) | 2.49340537 |
67 | Increased IgE level (HP:0003212) | 2.46797138 |
68 | Esophageal varix (HP:0002040) | 2.44792643 |
69 | Colitis (HP:0002583) | 2.43785202 |
70 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.40139700 |
71 | Hypergammaglobulinemia (HP:0010702) | 2.39512800 |
72 | Hemoptysis (HP:0002105) | 2.36983587 |
73 | Pulmonary infiltrates (HP:0002113) | 2.36678097 |
74 | Increased IgM level (HP:0003496) | 2.36556274 |
75 | Tetraparesis (HP:0002273) | 2.35967327 |
76 | Axonal loss (HP:0003447) | 2.34852944 |
77 | Encephalitis (HP:0002383) | 2.34488387 |
78 | Peritonitis (HP:0002586) | 2.33893109 |
79 | Spontaneous hematomas (HP:0007420) | 2.33748191 |
80 | Malnutrition (HP:0004395) | 2.31963396 |
81 | Amyloidosis (HP:0011034) | 2.31955581 |
82 | Hypobetalipoproteinemia (HP:0003563) | 2.31265725 |
83 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.27865474 |
84 | Chronic obstructive pulmonary disease (HP:0006510) | 2.25540349 |
85 | Obstructive lung disease (HP:0006536) | 2.25540349 |
86 | Hypercholesterolemia (HP:0003124) | 2.24438202 |
87 | Stomatitis (HP:0010280) | 2.23979134 |
88 | Thrombophlebitis (HP:0004418) | 2.23157030 |
89 | Epistaxis (HP:0000421) | 2.22855169 |
90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22761491 |
91 | Protrusio acetabuli (HP:0003179) | 2.21993379 |
92 | Spontaneous abortion (HP:0005268) | 2.21549315 |
93 | Hemorrhage of the eye (HP:0011885) | 2.20233224 |
94 | Absent frontal sinuses (HP:0002688) | 2.18877258 |
95 | Urticaria (HP:0001025) | 2.18628779 |
96 | Aortic aneurysm (HP:0004942) | 2.17770848 |
97 | Hematochezia (HP:0002573) | 2.16811396 |
98 | Episodic fever (HP:0001954) | 2.15608538 |
99 | Purpura (HP:0000979) | 2.15477840 |
100 | Anorexia (HP:0002039) | 2.14901523 |
101 | Abnormality of the pleura (HP:0002103) | 2.14739539 |
102 | Pulmonary embolism (HP:0002204) | 2.13778691 |
103 | Emphysema (HP:0002097) | 2.13637226 |
104 | Aortic dissection (HP:0002647) | 2.13016149 |
105 | Cervical subluxation (HP:0003308) | 2.12797347 |
106 | Increased serum ferritin (HP:0003281) | 2.08551048 |
107 | Dilatation of the ascending aorta (HP:0005111) | 2.08203859 |
108 | Osteomyelitis (HP:0002754) | 2.07903149 |
109 | Meningitis (HP:0001287) | 2.07772471 |
110 | Abnormality of iron homeostasis (HP:0011031) | 2.06676563 |
111 | Abnormality of the pericardium (HP:0001697) | 2.05326472 |
112 | Leukocytosis (HP:0001974) | 2.04677321 |
113 | Albinism (HP:0001022) | 2.02588953 |
114 | Keratoconjunctivitis sicca (HP:0001097) | 2.02083881 |
115 | Abnormality of the peritoneum (HP:0002585) | 2.01824752 |
116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00654308 |
117 | Osteolytic defects of the hand bones (HP:0009699) | 2.00654308 |
118 | Prolonged bleeding time (HP:0003010) | 1.99650725 |
119 | Inflammation of the large intestine (HP:0002037) | 1.98584851 |
120 | Gangrene (HP:0100758) | 1.98495602 |
121 | Menorrhagia (HP:0000132) | 1.96851309 |
122 | Chronic sinusitis (HP:0011109) | 1.95752379 |
123 | Gastrointestinal stroma tumor (HP:0100723) | 1.95652243 |
124 | Gastrointestinal inflammation (HP:0004386) | 1.94855845 |
125 | Autoimmune hemolytic anemia (HP:0001890) | 1.94508364 |
126 | Abnormality of T cell number (HP:0011839) | 1.93958269 |
127 | Chest pain (HP:0100749) | 1.93186207 |
128 | Restrictive lung disease (HP:0002091) | 1.92544657 |
129 | Increased CSF protein (HP:0002922) | 1.91337214 |
130 | Acne (HP:0001061) | 1.90620319 |
131 | Agammaglobulinemia (HP:0004432) | 1.90119821 |
132 | Papilledema (HP:0001085) | 1.89047994 |
133 | Abnormality of T cells (HP:0002843) | 1.89015768 |
134 | Polycythemia (HP:0001901) | 1.88793800 |
135 | Eosinophilia (HP:0001880) | 1.88655253 |
136 | Petechiae (HP:0000967) | 1.88616973 |
137 | Skin nodule (HP:0200036) | 1.88358871 |
138 | Abnormality of the endocardium (HP:0004306) | 1.88208919 |
139 | Vascular tortuosity (HP:0004948) | 1.86724550 |
140 | Cheilitis (HP:0100825) | 1.85500527 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FGFR4 | 3.81824111 |
2 | * TYK2 | 3.62565351 |
3 | MAP3K14 | 3.62134490 |
4 | TBK1 | 3.41618161 |
5 | ERN1 | 3.37284504 |
6 | IKBKE | 3.25126563 |
7 | JAK3 | 3.21961433 |
8 | KIT | 2.79469961 |
9 | MAP4K1 | 2.78028644 |
10 | * JAK1 | 2.76769289 |
11 | RIPK4 | 2.46280993 |
12 | BLK | 2.31248850 |
13 | MAP3K13 | 2.24707696 |
14 | EPHB1 | 2.22731428 |
15 | IRAK3 | 2.18670371 |
16 | TAOK3 | 2.16435321 |
17 | IRAK4 | 2.07858676 |
18 | IKBKB | 1.92974752 |
19 | FGFR3 | 1.89253054 |
20 | EPHA3 | 1.74863452 |
21 | FRK | 1.74255345 |
22 | SIK1 | 1.73959882 |
23 | PRPF4B | 1.72987363 |
24 | CDC42BPA | 1.61275322 |
25 | DDR2 | 1.58050973 |
26 | CSK | 1.56461953 |
27 | TNK2 | 1.49321141 |
28 | GRK7 | 1.48202361 |
29 | CHUK | 1.47619775 |
30 | JAK2 | 1.46128703 |
31 | ZAP70 | 1.41650987 |
32 | MAP3K3 | 1.41008214 |
33 | TXK | 1.33408857 |
34 | SYK | 1.32623651 |
35 | CSF1R | 1.26847236 |
36 | SIK2 | 1.26584876 |
37 | HCK | 1.25012727 |
38 | BMPR2 | 1.22706119 |
39 | PTK6 | 1.20979450 |
40 | PRKD2 | 1.17907601 |
41 | BTK | 1.04673545 |
42 | PBK | 1.01345497 |
43 | STK3 | 1.00757412 |
44 | TRIB3 | 1.00308410 |
45 | MAPK7 | 1.00097950 |
46 | STK10 | 0.98344198 |
47 | HIPK2 | 0.98270921 |
48 | MAPK11 | 0.96672851 |
49 | CAMK1D | 0.94495314 |
50 | * LCK | 0.93422384 |
51 | PIM2 | 0.93137548 |
52 | RIPK1 | 0.92681268 |
53 | MATK | 0.91867776 |
54 | MAP3K10 | 0.90377178 |
55 | TGFBR2 | 0.89983433 |
56 | PTK2B | 0.85436845 |
57 | BMX | 0.85432747 |
58 | MARK3 | 0.84931073 |
59 | NEK9 | 0.84645117 |
60 | PIK3CG | 0.84429837 |
61 | FLT3 | 0.82505371 |
62 | PKN2 | 0.82076346 |
63 | LYN | 0.80451765 |
64 | MARK2 | 0.79250059 |
65 | RPS6KA4 | 0.78825195 |
66 | FER | 0.76628037 |
67 | LATS1 | 0.74419319 |
68 | ITK | 0.71837141 |
69 | ADRBK2 | 0.71689344 |
70 | PIM1 | 0.71443240 |
71 | CDK12 | 0.71317408 |
72 | FGFR2 | 0.68836902 |
73 | FES | 0.66968961 |
74 | TAOK1 | 0.66442150 |
75 | CAMK1G | 0.66386462 |
76 | PDGFRA | 0.65509653 |
77 | GRK6 | 0.65082745 |
78 | NLK | 0.65037572 |
79 | FGR | 0.64939758 |
80 | IRAK1 | 0.64689186 |
81 | LRRK2 | 0.62814415 |
82 | MAP2K6 | 0.62306688 |
83 | TAOK2 | 0.62074437 |
84 | MAP3K2 | 0.60976494 |
85 | EGFR | 0.60304173 |
86 | PRKCQ | 0.59769102 |
87 | NUAK1 | 0.59669495 |
88 | MAP3K6 | 0.58164156 |
89 | CDK6 | 0.56724578 |
90 | ABL1 | 0.55656310 |
91 | TTN | 0.55391692 |
92 | MYLK | 0.55323751 |
93 | MAP2K3 | 0.52251159 |
94 | TEC | 0.50838579 |
95 | MAP3K5 | 0.49626736 |
96 | DAPK2 | 0.49373990 |
97 | STK4 | 0.48255601 |
98 | MAP3K11 | 0.47237019 |
99 | INSRR | 0.46458944 |
100 | MST1R | 0.45822104 |
101 | MAPK12 | 0.44852214 |
102 | PRKD1 | 0.44729250 |
103 | SGK3 | 0.44687129 |
104 | TRPM7 | 0.43914471 |
105 | PAK3 | 0.43483859 |
106 | YES1 | 0.43231448 |
107 | AKT3 | 0.41911430 |
108 | MAP3K7 | 0.40858727 |
109 | PDK1 | 0.40625708 |
110 | PRKCH | 0.39929226 |
111 | PDGFRB | 0.39242849 |
112 | ABL2 | 0.38545944 |
113 | PRKAA2 | 0.38145904 |
114 | PDPK1 | 0.37893632 |
115 | RET | 0.37821532 |
116 | STK38 | 0.37729038 |
117 | SGK2 | 0.34331947 |
118 | ERBB4 | 0.34023953 |
119 | ACVR1B | 0.33765405 |
120 | ALK | 0.33467073 |
121 | PRKCD | 0.33145767 |
122 | EIF2AK2 | 0.32822043 |
123 | MELK | 0.32309451 |
124 | FYN | 0.31144152 |
125 | KDR | 0.30812136 |
126 | MAPK4 | 0.30722959 |
127 | MAP3K1 | 0.29086559 |
128 | SIK3 | 0.28999833 |
129 | PTK2 | 0.27288870 |
130 | SRC | 0.26687660 |
131 | IGF1R | 0.26063282 |
132 | ERBB2 | 0.24715144 |
133 | INSR | 0.23279340 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.30801355 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.76515833 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.66757213 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.39185364 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37776670 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29185114 |
7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.23520619 |
8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.22588354 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.17365675 |
10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.05400008 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.05356368 |
12 | * Measles_Homo sapiens_hsa05162 | 1.99571356 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.84657483 |
14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.81746765 |
15 | Allograft rejection_Homo sapiens_hsa05330 | 1.76257132 |
16 | * Influenza A_Homo sapiens_hsa05164 | 1.72744651 |
17 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71524646 |
18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70530041 |
19 | Pertussis_Homo sapiens_hsa05133 | 1.63182669 |
20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.59751904 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56846121 |
22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50661817 |
23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50138842 |
24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.48919011 |
25 | Malaria_Homo sapiens_hsa05144 | 1.48096932 |
26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47445097 |
27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42709896 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40540020 |
29 | Tuberculosis_Homo sapiens_hsa05152 | 1.38168135 |
30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37050759 |
31 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.35480609 |
32 | Legionellosis_Homo sapiens_hsa05134 | 1.33237414 |
33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.31025984 |
34 | ABC transporters_Homo sapiens_hsa02010 | 1.23310399 |
35 | * Hepatitis C_Homo sapiens_hsa05160 | 1.18469362 |
36 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17188492 |
37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16026181 |
38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06550110 |
39 | Peroxisome_Homo sapiens_hsa04146 | 1.04793945 |
40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03381757 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02065163 |
42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01133203 |
43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00161646 |
44 | Lysosome_Homo sapiens_hsa04142 | 0.99695537 |
45 | Apoptosis_Homo sapiens_hsa04210 | 0.96479954 |
46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91434510 |
47 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90548157 |
48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89997446 |
49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89922609 |
50 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88604782 |
51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88232417 |
52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87454804 |
53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84869441 |
54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84481035 |
55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81464288 |
56 | Asthma_Homo sapiens_hsa05310 | 0.80609887 |
57 | Bile secretion_Homo sapiens_hsa04976 | 0.80456392 |
58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80453534 |
59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80431972 |
60 | * Hepatitis B_Homo sapiens_hsa05161 | 0.78661577 |
61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76261605 |
62 | Salmonella infection_Homo sapiens_hsa05132 | 0.76187003 |
63 | Lysine degradation_Homo sapiens_hsa00310 | 0.75580638 |
64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74431172 |
65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73931506 |
66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72204055 |
67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71210691 |
68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70387506 |
69 | Amoebiasis_Homo sapiens_hsa05146 | 0.69758088 |
70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69708457 |
71 | Insulin resistance_Homo sapiens_hsa04931 | 0.68153372 |
72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68074959 |
73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.67768185 |
74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66337581 |
75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65887892 |
76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65646909 |
77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65316891 |
78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65309843 |
79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62981768 |
80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62939775 |
81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62703357 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.62471034 |
83 | Shigellosis_Homo sapiens_hsa05131 | 0.61515462 |
84 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61140341 |
85 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59689540 |
86 | Phagosome_Homo sapiens_hsa04145 | 0.58959423 |
87 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58465045 |
88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57413535 |
89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57047868 |
90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55714340 |
91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55316547 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53738443 |
93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53213286 |
94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53013857 |
95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52974077 |
96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49915368 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49724863 |
98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49442739 |
99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49123847 |
100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49047058 |
101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47044989 |
102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46654096 |
103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46429474 |
104 | Endocytosis_Homo sapiens_hsa04144 | 0.45552668 |
105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45508561 |
106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44445045 |
107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43755310 |
108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43141804 |
109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42984297 |
110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42260888 |
111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41900467 |
112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41609960 |
113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40686526 |
114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40516247 |
115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40506039 |
116 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39885126 |
117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39705342 |
118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39437393 |
119 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39217203 |
120 | Focal adhesion_Homo sapiens_hsa04510 | 0.38420533 |
121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38305881 |
122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36766350 |
123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35142040 |
124 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33721728 |
125 | Platelet activation_Homo sapiens_hsa04611 | 0.33674322 |
126 | Prostate cancer_Homo sapiens_hsa05215 | 0.33043204 |
127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28331936 |
128 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.28267447 |
129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27615025 |
130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26520178 |
131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26333349 |
132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24159632 |